GO:0006310 DNA recombination: Mechanism and Genes

DNA recombination (GO:0006310) is a fundamental biological process in which a new genotype is formed by reassortment of genes, yielding gene combinations that differ from those present in the parents. This process is central to genetic diversity, genome stability, and the repair of DNA damage, and it is conserved across all domains of life. In eukaryotes, recombination can occur through chromosome assortment, intrachromosomal recombination, or nonreciprocal interchromosomal recombination, with interchromosomal recombination occurring by crossing over. In bacteria, recombination may proceed by genetic transformation, conjugation, transduction, or F-duction. Mechanistically, DNA recombination is intimately connected to DNA replication and repair. The RecA/Rad51-family recombinases catalyze the key steps of homologous pairing and strand exchange, allowing a single-stranded DNA to invade a homologous duplex and form a joint molecule. Single-molecule studies have revealed the dynamic mechanics of these nucleoprotein filaments and the energy landscapes that govern strand exchange. In archaea, recombination and repair systems share many features with bacterial and eukaryotic pathways, underscoring the deep evolutionary conservation of this process. For researchers, GO:0006310 provides a conceptual and experimental framework for studying genome stability, genetic diversity, and DNA repair. Understanding recombination is essential for interpreting mutagenesis, cancer predisposition, and the development of gene-editing and gene-therapy tools. The sections below summarize the definition, mechanism, key genes, disease links, and research methods associated with DNA recombination.

DNA recombination (GO:0006310) is any process in which a new genotype is formed by reassortment of genes, resulting in gene combinations different from those that were present in the parents. In eukaryotes, genetic recombination can occur by chromosome assortment, intrachromosomal recombination, or nonreciprocal interchromosomal recombination, and interchromosomal recombination occurs by crossing over. In bacteria, recombination may occur by genetic transformation, conjugation, transduction, or F-duction.

DNA recombination is essential for generating genetic diversity, maintaining genome stability, and repairing DNA damage, and its dysregulation is linked to cancer and other genome-instability disorders. Because recombination is conserved from bacteria to humans, it provides a tractable experimental system for understanding fundamental DNA transactions and for developing gene-editing and gene-therapy technologies.

The following genes and proteins are central to DNA recombination (GO:0006310) and are widely studied in bacteria, archaea, and eukaryotes.

DNA recombination is regulated at multiple levels, including cell-cycle-dependent expression and post-translational modification of recombinases and accessory factors. The process is tightly coupled to DNA replication and repair checkpoints, ensuring that recombination occurs only when needed. In bacteria, recombination is regulated by the availability of RecA and accessory proteins, as well as by environmental stresses that induce the SOS response. In eukaryotes, cyclin-dependent kinases and checkpoint kinases control the assembly and disassembly of recombination complexes. Meiotic recombination is additionally regulated by developmental programs that determine the timing and frequency of crossover events.

Defects in homologous recombination, including mutations in BRCA1, BRCA2, and RAD51 paralogs, lead to genome instability and increased cancer predisposition. Tumors with recombination defects often rely on alternative repair pathways, making them sensitive to targeted therapies such as PARP inhibitors. Understanding recombination mechanisms is therefore central to cancer biology and treatment.

Meiotic recombination is required for proper chromosome segregation, and its failure can lead to aneuploidy and infertility. Recent evidence suggests that meiotic recombination may be initiated by copy choice during DNA synthesis, which has implications for understanding recombination-associated birth defects.

In bacteria such as Helicobacter pylori, recombination and DNA repair pathways contribute to genetic diversity and survival in hostile environments. Horizontal gene transfer via transformation, conjugation, transduction, and F-duction can spread antibiotic resistance genes, making recombination a key driver of pathogenesis.

Recombination-based methods such as AAVLINK enable large cargo delivery for gene therapy, expanding the therapeutic potential of DNA recombination. These approaches leverage the natural homology-directed repair machinery to achieve precise genome modifications.

Single-molecule techniques such as optical tweezers and fluorescence microscopy allow real-time observation of recombinase filament assembly, homology search, and strand exchange. These methods provide quantitative insights into the mechanics and energy landscapes of DNA recombination.

Classical genetic assays, including recombination frequency measurements and reporter constructs, are used to quantify recombination in bacteria, archaea, and eukaryotes. Biochemical reconstitution with purified recombinases enables detailed mechanistic studies of strand exchange and joint molecule resolution.

CRISPR library screening and next-generation sequencing can identify genes required for DNA recombination and map recombination hotspots. These approaches are particularly powerful for discovering novel recombination factors and for studying meiotic recombination.

Fluorescence imaging of recombination foci (e.g., RAD51 foci) and live-cell reporters allow researchers to monitor recombination in situ. These assays are widely used to assess recombination proficiency in cancer cells and to evaluate gene-editing outcomes.

Researchers studying DNA recombination-related genes often need to determine whether a candidate gene is causally involved in recombination, genome stability, or disease. EDITGENE provides a comprehensive suite of CRISPR-based cell models and screening services to accelerate this research.

DNA recombination (GO:0006310) is a conserved and mechanistically rich biological process that underlies genetic diversity, genome stability, and DNA repair. Its study spans bacteria, archaea, and eukaryotes, with important implications for cancer, infertility, and gene therapy. By combining CRISPR-based models with advanced screening and imaging methods, researchers can continue to uncover the molecular details and translational potential of DNA recombination.